SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9815	Companies
196895	Keywords
127959	Articles
104711	Press releases

Home
Companies
SANOFI-AVENTIS

BRIEF

published on 09/24/2025 at 07:05, 4 months 11 days ago

Sanofi publie son aide-mémoire pour le troisième trimestre 2025

Relations Avec Les Investisseurs Sanofi Annonce Des Résultats Modélisation Financière T3 2025
BRIEF

published on 09/24/2025 at 07:05, 4 months 11 days ago

Sanofi Releases Q3 2025 Aide Mémoire

Investor Relations Sanofi Financial Modeling Results Announcement Q3 2025
PRESS RELEASE

published on 09/24/2025 at 07:05, 4 months 11 days ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits $625 million to Sanofi Ventures to boost biotech and digital health investments. Focus on immunology, rare diseases, neurology, vaccines

Digital Health Investment Biotech Ventures Sanofi
PRESS RELEASE

published on 09/24/2025 at 07:05, 4 months 11 days ago

Communiqué de presse : Sanofi engage 625 millions de dollars supplémentaires dans Sanofi Ventures, afin d’accélérer ses investissements dans les biotechnologies et l’innovation en matière de santé numérique
Sanofi investit 625 millions de dollars supplémentaires dans Sanofi Ventures pour accélérer les investissements en biotechnologies et innovation numérique dans la santé

Investissement Innovation Santé Numérique Sanofi Biotechnologies
PRESS RELEASE

published on 09/24/2025 at 07:00, 4 months 11 days ago

Press release: Availability of the Q3 2025 Aide mémoire
Sanofi announces availability of Q3 2025 Aide mémoire for financial modeling purposes. Document covers non-comparable items, foreign currency impact, and share count

Investors Sanofi Financial Modeling Aide Mémoire Q3 2025
BRIEF

published on 09/23/2025 at 07:05, 4 months 12 days ago

La thérapie SAR446268 de Sanofi progresse aux États-Unis

Thérapie Génique Sanofi SAR446268 FDA Admission Dystrophie Myotonique
BRIEF

published on 09/23/2025 at 07:05, 4 months 12 days ago

Sanofi's SAR446268 Therapy Advances in the United States

Gene Therapy Sanofi SAR446268 FDA Admission Myotonic Dystrophy
PRESS RELEASE

published on 09/23/2025 at 07:00, 4 months 12 days ago

Press Release: Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1
Sanofi's SAR446268 granted US fast track designation for non-congenital myotonic dystrophy type 1. AAV gene therapy aims to silence DMPK expression, addressing symptoms and filling unmet need

AAV Gene Therapy Sanofi Fast Track Designation SAR446268 Myotonic Dystrophy Type 1
PRESS RELEASE

published on 09/23/2025 at 07:00, 4 months 12 days ago

Communiqué de presse : La thérapie SAR446268 de Sanofi obtient son admission dans la procédure accélérée américaine pour le traitement de la dystrophie myotonique non congénitale de type 1
Sanofi's SAR446268 therapy granted fast track designation by US FDA for treating non-congenital myotonic dystrophy type 1. Innovative gene therapy aims to address unmet medical need

FDA Gene Therapy Sanofi SAR446268 Myotonic Dystrophy
BRIEF

published on 09/17/2025 at 07:05, 4 months 18 days ago

Le Brivekimig de Sanofi s'avère prometteur dans le traitement de l'hidradénite suppurée

Brivekimig Hidradénite Suppurée Étude De Phase 2a Technologie Des Nanocorps Maladies À Médiation Immunitaire

Accesswire

Published on 02/06/2026 at 00:00, 24 minutes ago

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
Published on 02/05/2026 at 23:15, 1 hour 9 minutes ago

Amarc Further Expands Its Toodoggone Technical Team
Published on 02/05/2026 at 23:00, 1 hour 24 minutes ago

Grounded People Announces Non-Brokered Private Placement and Strategic Review
Published on 02/05/2026 at 21:00, 3 hours 24 minutes ago

Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions
Published on 02/05/2026 at 18:50, 5 hours 34 minutes ago

Athena Gold Provides Exploration Update From Nevada and Ontario

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 4 hours 56 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 5 hours 38 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 6 hours 15 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 6 hours 29 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 6 hours 44 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 4 hours 59 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 4 hours 59 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 5 hours 9 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 5 hours 9 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 5 hours 9 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE